GLAXOSMITHKLINE PLC-SPON ADR

GSK stock holders 13F

5 superinvestors reported owning GSK (ADR) according to the gurus' 2022 Q1 reports.

Top 5 gurus who own (GSK) GLAXOSMITHKLINE PLC-SPON ADR

The 5 super investors (holders) owning GSK (by the percentage (%) of portfolio) are Thomas Graham, Alan, Irving Kahns - Kahn Brothers Group (7.89%), Mark A. Hillman - Hillman Value Fund (2.83%), V. D. Dodge, E. M. Cox - Dodge & Cox Stock Fund (2.69%), B. Tweedy, Ch. Browne - Tweedy, Browne Co All Funds (US) (0.28%) and Sarah Ketterer - Causeway Capital Management (0.27%) as of their 2022 Q1 reports.

To check the latest activities of the top GSK shareholders between value investors, please click on the "Activity" tab.

To see the historical data of GSK's holders please click on the "2022 Q1" dropdown menu and select the date.

# of holders: 5
Period: 2022 Q1
Type: ADR
History
Name
Company
% of
Portfolio
Shares*
Price*
Value
% (shares)
Activity
% change to
Portfolio
B. Tweedy, Ch. Browne
Tweedy, Browne Co All Funds (US)
0.28%
157,455
$54.45
$8,573,000
-1.44% (-2,303)
-0.00%
Mark A. Hillman
Hillman Value Fund
2.83%
128,000
$54.45
$6,969,600
Sarah Ketterer
Causeway Capital Management
0.27%
177,763
$54.45
$9,679,300
+44.71% (+54,923)
+0.08%
Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
7.89%
1,141,331
$54.45
$62,145,788
-0.83% (-9,524)
-0.07%
V. D. Dodge, E. M. Cox
Dodge & Cox Stock Fund
2.69%
32,457,367
$54.45
$1,767,303,635
Current price: $33.96 37.63% AVG reported hold price*: $54.45

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.